OP-7 Further exploration of differences between lean and non-lean metabolic dysfunction-associated steatotic liver disease (MASLD) in Latino subjects: PNPLA3 frequency and lipidomic profiles
Conflict of interest: Yes, Fondecyt # 1241450 Introduction and Objectives: Background: There is limited information on features of lean MASLD patients in Latino subjects. We aimed to analyze the features of MASLD in Chilean patients with normal body mass index (BMI), the frequency of the rs738409 ri...
Saved in:
| Main Authors: | , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2024-12-01
|
| Series: | Annals of Hepatology |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S1665268124003880 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1846138641066229760 |
|---|---|
| author | MARIA AYALA VALVERDE Jorge Arnold Alvarez Gustavo Ayares Francisco Barrera Daniel Cabrera Luis Antonio Diaz Juan Pablo Arab Ibon Martinez-Arranz Cristina Alonso Jesús M. Bañales Marco Arrese |
| author_facet | MARIA AYALA VALVERDE Jorge Arnold Alvarez Gustavo Ayares Francisco Barrera Daniel Cabrera Luis Antonio Diaz Juan Pablo Arab Ibon Martinez-Arranz Cristina Alonso Jesús M. Bañales Marco Arrese |
| author_sort | MARIA AYALA VALVERDE |
| collection | DOAJ |
| description | Conflict of interest: Yes, Fondecyt # 1241450 Introduction and Objectives: Background: There is limited information on features of lean MASLD patients in Latino subjects. We aimed to analyze the features of MASLD in Chilean patients with normal body mass index (BMI), the frequency of the rs738409 risk polymorphism (PNPLA3 I148M variant) and metabolomic profiles in Chilean individuals with MASLD. Patients / Materials and Methods: A cross-sectional study involving 181 randomly-selected participants diagnosed with MASLD from the prospective Maule Cohort (BMC Public Health. 2016;16:122). Participants were categorized into lean, overweight, and obese groups based on their BMI. The presence of the rs738409 polymorphism was examined using Sanger sequencing. Metabolomics was assessed using UHPLC-MS in a separate group of biopsy-proven MASLD patients. Statistical analyses of clinical data and genotypes encompassed Fisher's exact test, Chi-square test, Kruskal-Wallis test. Results and Discussion: 31.49% (57) were classified as thin, 36.3% (61) as overweight and 39.8% (67) as obese. Higher ALT levels (p=0.004) and body fat percentage in obese subjects were the only significant differences found among the groups. The allelic frequency of rs738409 was similar among groups 77.1%, 83.6% and 82.5% in lean, overweight, and obese subjects, respectively (n.s.). Circulating metabolome showed increased levels of ceramides in overweight and obese patients compared to lean subjects (p<0.001 for five different species). The increment is higher if all the MASLD patients were considered (Figure). Serum bile acids, particularly chenodeoxycholic acid (p<0.001) and glycochenodeoxycholic acid (p=0.024), were also increased. Lipidomic analysis also showed an increase of polyunsaturated diglyceride and triglyceride species in overweight and obese compared to lean subjects. Among them, most of the species included linoleic acid or alpha-linoleic acid in their esterified chains. Conclusions: PNPLA3 risk allele was equally frequent in lean and non-lean Chilean MASLD patients. Metabolomic differences were found with non-lean subjects exhibiting higher levels of ceramides and bile acid species compared with lean patients. (Supported by Fondecyt # 1241450) |
| format | Article |
| id | doaj-art-eaf891990b604b6aaa23afcde128c1f8 |
| institution | Kabale University |
| issn | 1665-2681 |
| language | English |
| publishDate | 2024-12-01 |
| publisher | Elsevier |
| record_format | Article |
| series | Annals of Hepatology |
| spelling | doaj-art-eaf891990b604b6aaa23afcde128c1f82024-12-07T08:25:21ZengElsevierAnnals of Hepatology1665-26812024-12-0129101605OP-7 Further exploration of differences between lean and non-lean metabolic dysfunction-associated steatotic liver disease (MASLD) in Latino subjects: PNPLA3 frequency and lipidomic profilesMARIA AYALA VALVERDE0Jorge Arnold Alvarez1Gustavo Ayares2Francisco Barrera3Daniel Cabrera4Luis Antonio Diaz5Juan Pablo Arab6Ibon Martinez-Arranz7Cristina Alonso8Jesús M. Bañales9Marco Arrese10Departamento de Gastroenterología Facultad de Medicina Pontificia Universidad Católica de Chile, ChileDepartamento de Gastroenterología Facultad de Medicina Pontificia Universidad Católica de Chile, ChilePontificia Universidad Católica de Chile, Santiago, ChileDepartamento de Gastroenterología Facultad de Medicina Pontificia Universidad Católica de Chile, ChileDepartamento de Gastroenterología Facultad de Medicina Pontificia Universidad Católica de Chile, ChileDepartamento de Gastroenterología Facultad de Medicina Pontificia Universidad Católica de Chile, ChileVirginia Commonwealth University School of Medicine, Richmond, VA (USA), ChileOWL Metabolomics, Derio (Spain), ChileOWL Metabolomics, Derio (Spain), ChileBioguipuzcoa Research Institute, San Sebastian (Spain), ChileDepartamento de Gastroenterología Facultad de Medicina Pontificia Universidad Católica de Chile, ChileConflict of interest: Yes, Fondecyt # 1241450 Introduction and Objectives: Background: There is limited information on features of lean MASLD patients in Latino subjects. We aimed to analyze the features of MASLD in Chilean patients with normal body mass index (BMI), the frequency of the rs738409 risk polymorphism (PNPLA3 I148M variant) and metabolomic profiles in Chilean individuals with MASLD. Patients / Materials and Methods: A cross-sectional study involving 181 randomly-selected participants diagnosed with MASLD from the prospective Maule Cohort (BMC Public Health. 2016;16:122). Participants were categorized into lean, overweight, and obese groups based on their BMI. The presence of the rs738409 polymorphism was examined using Sanger sequencing. Metabolomics was assessed using UHPLC-MS in a separate group of biopsy-proven MASLD patients. Statistical analyses of clinical data and genotypes encompassed Fisher's exact test, Chi-square test, Kruskal-Wallis test. Results and Discussion: 31.49% (57) were classified as thin, 36.3% (61) as overweight and 39.8% (67) as obese. Higher ALT levels (p=0.004) and body fat percentage in obese subjects were the only significant differences found among the groups. The allelic frequency of rs738409 was similar among groups 77.1%, 83.6% and 82.5% in lean, overweight, and obese subjects, respectively (n.s.). Circulating metabolome showed increased levels of ceramides in overweight and obese patients compared to lean subjects (p<0.001 for five different species). The increment is higher if all the MASLD patients were considered (Figure). Serum bile acids, particularly chenodeoxycholic acid (p<0.001) and glycochenodeoxycholic acid (p=0.024), were also increased. Lipidomic analysis also showed an increase of polyunsaturated diglyceride and triglyceride species in overweight and obese compared to lean subjects. Among them, most of the species included linoleic acid or alpha-linoleic acid in their esterified chains. Conclusions: PNPLA3 risk allele was equally frequent in lean and non-lean Chilean MASLD patients. Metabolomic differences were found with non-lean subjects exhibiting higher levels of ceramides and bile acid species compared with lean patients. (Supported by Fondecyt # 1241450)http://www.sciencedirect.com/science/article/pii/S1665268124003880 |
| spellingShingle | MARIA AYALA VALVERDE Jorge Arnold Alvarez Gustavo Ayares Francisco Barrera Daniel Cabrera Luis Antonio Diaz Juan Pablo Arab Ibon Martinez-Arranz Cristina Alonso Jesús M. Bañales Marco Arrese OP-7 Further exploration of differences between lean and non-lean metabolic dysfunction-associated steatotic liver disease (MASLD) in Latino subjects: PNPLA3 frequency and lipidomic profiles Annals of Hepatology |
| title | OP-7 Further exploration of differences between lean and non-lean metabolic dysfunction-associated steatotic liver disease (MASLD) in Latino subjects: PNPLA3 frequency and lipidomic profiles |
| title_full | OP-7 Further exploration of differences between lean and non-lean metabolic dysfunction-associated steatotic liver disease (MASLD) in Latino subjects: PNPLA3 frequency and lipidomic profiles |
| title_fullStr | OP-7 Further exploration of differences between lean and non-lean metabolic dysfunction-associated steatotic liver disease (MASLD) in Latino subjects: PNPLA3 frequency and lipidomic profiles |
| title_full_unstemmed | OP-7 Further exploration of differences between lean and non-lean metabolic dysfunction-associated steatotic liver disease (MASLD) in Latino subjects: PNPLA3 frequency and lipidomic profiles |
| title_short | OP-7 Further exploration of differences between lean and non-lean metabolic dysfunction-associated steatotic liver disease (MASLD) in Latino subjects: PNPLA3 frequency and lipidomic profiles |
| title_sort | op 7 further exploration of differences between lean and non lean metabolic dysfunction associated steatotic liver disease masld in latino subjects pnpla3 frequency and lipidomic profiles |
| url | http://www.sciencedirect.com/science/article/pii/S1665268124003880 |
| work_keys_str_mv | AT mariaayalavalverde op7furtherexplorationofdifferencesbetweenleanandnonleanmetabolicdysfunctionassociatedsteatoticliverdiseasemasldinlatinosubjectspnpla3frequencyandlipidomicprofiles AT jorgearnoldalvarez op7furtherexplorationofdifferencesbetweenleanandnonleanmetabolicdysfunctionassociatedsteatoticliverdiseasemasldinlatinosubjectspnpla3frequencyandlipidomicprofiles AT gustavoayares op7furtherexplorationofdifferencesbetweenleanandnonleanmetabolicdysfunctionassociatedsteatoticliverdiseasemasldinlatinosubjectspnpla3frequencyandlipidomicprofiles AT franciscobarrera op7furtherexplorationofdifferencesbetweenleanandnonleanmetabolicdysfunctionassociatedsteatoticliverdiseasemasldinlatinosubjectspnpla3frequencyandlipidomicprofiles AT danielcabrera op7furtherexplorationofdifferencesbetweenleanandnonleanmetabolicdysfunctionassociatedsteatoticliverdiseasemasldinlatinosubjectspnpla3frequencyandlipidomicprofiles AT luisantoniodiaz op7furtherexplorationofdifferencesbetweenleanandnonleanmetabolicdysfunctionassociatedsteatoticliverdiseasemasldinlatinosubjectspnpla3frequencyandlipidomicprofiles AT juanpabloarab op7furtherexplorationofdifferencesbetweenleanandnonleanmetabolicdysfunctionassociatedsteatoticliverdiseasemasldinlatinosubjectspnpla3frequencyandlipidomicprofiles AT ibonmartinezarranz op7furtherexplorationofdifferencesbetweenleanandnonleanmetabolicdysfunctionassociatedsteatoticliverdiseasemasldinlatinosubjectspnpla3frequencyandlipidomicprofiles AT cristinaalonso op7furtherexplorationofdifferencesbetweenleanandnonleanmetabolicdysfunctionassociatedsteatoticliverdiseasemasldinlatinosubjectspnpla3frequencyandlipidomicprofiles AT jesusmbanales op7furtherexplorationofdifferencesbetweenleanandnonleanmetabolicdysfunctionassociatedsteatoticliverdiseasemasldinlatinosubjectspnpla3frequencyandlipidomicprofiles AT marcoarrese op7furtherexplorationofdifferencesbetweenleanandnonleanmetabolicdysfunctionassociatedsteatoticliverdiseasemasldinlatinosubjectspnpla3frequencyandlipidomicprofiles |